Subcutaneous panniculitis-like T-cell lymphoma: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{SI}} | ||
'''For patient information, click [[Insert page name here (patient information)|Insert page name here]]''' | |||
{{CMG}}; {{AE}} {{AS}} | |||
{{SK}} | |||
== | == Overview == | ||
== | == Pathophysiology== | ||
=== Associated Conditions=== | |||
== | ===Microscopic Pathology=== | ||
== | ==Causes== | ||
There are no established causes for subcutaneous panniculitis-like T-cell lymphoma. | |||
==Differentiating type page name here from other Diseases== | |||
Subcutaneous panniculitis-like T-cell lymphoma must be differentiated from other diseases such as: | |||
* [[Benign panniculitis]] | |||
* [[Cutaneous T-cell lymphoma]] | |||
* [[Extranodal NK/T cell lymphoma]] | |||
== Epidemiology and Demographics == | |||
===Age=== | |||
The incidence of subcutaneous panniculitis-like T-cell lymphoma increases with age; the median age at diagnosis is 35 years. | |||
===Gender=== | |||
Females are more commonly affected with subcutaneous panniculitis-like T-cell lymphoma than males. | |||
== Risk Factors == | |||
There are no established risk factors for subcutaneous panniculitis-like T-cell lymphoma. | |||
== Screening == | |||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for subcutaneous panniculitis-like T-cell lymphoma.<ref name=uspreventive> Recommendations. U.S Preventive Services Task Force. Accessed on March 8, 2016</ref> | |||
== Natural History, Complications and Prognosis== | |||
== | == Diagnosis == | ||
===Staging=== | |||
Staging for subcutaneous panniculitis-like T-cell lymphoma is provided in the following table:<ref>{{Cite journal| doi = 10.1200/JCO.2013.54.8800| issn = 1527-7755| volume = 32| issue = 27| pages = 3059–3068| last1 = Cheson| first1 = Bruce D.| last2 = Fisher| first2 = Richard I.| last3 = Barrington| first3 = Sally F.| last4 = Cavalli| first4 = Franco| last5 = Schwartz| first5 = Lawrence H.| last6 = Zucca| first6 = Emanuele| last7 = Lister| first7 = T. Andrew| last8 = Alliance, Australasian Leukaemia and Lymphoma Group| last9 = Eastern Cooperative Oncology Group| last10 = European Mantle Cell Lymphoma Consortium| last11 = Italian Lymphoma Foundation| last12 = European Organisation for Research| last13 = Treatment of Cancer/Dutch Hemato-Oncology Group| last14 = Grupo Español de Médula Ósea| last15 = German High-Grade Lymphoma Study Group| last16 = German Hodgkin's Study Group| last17 = Japanese Lymphorra Study Group| last18 = Lymphoma Study Association| last19 = NCIC Clinical Trials Group| last20 = Nordic Lymphoma Study Group| last21 = Southwest Oncology Group| last22 = United Kingdom National Cancer Research Institute| title = Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification| journal = Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology| date = 2014-09-20| pmid = 25113753}}</ref> | |||
== | {| style="border: 0px; font-size: 90%; margin: 3px;" align=center | ||
|+ '''Revised staging system for primary nodal lymphomas (Lugano classification)''' | |||
! style="background: #4479BA; color:#FFF;" | Stage | |||
! style="background: #4479BA; color:#FFF;" | Involvement | |||
! style="background: #4479BA; color:#FFF;" | Extranodal (E) status | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''Limited''' | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage I | |||
| style="padding: 5px 5px; background: #F5F5F5;" | One node or a group of adjacent nodes | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Single extranodal lesions without nodal involvement | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage II | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Two or more nodal groups on the same side of the diaphragm | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage I or II by nodal extent with limited contiguous extranodal involvement | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage II bulky | |||
| style="padding: 5px 5px; background: #F5F5F5;" | II as above with "bulky" disease | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Not applicable | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''Advanced''' | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage III | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Not applicable | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage IV | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Additional noncontiguous extralymphatic involvement | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Not applicable | |||
|} | |||
== [[Subcutaneous panniculitis-like T-cell lymphoma | === Symptoms === | ||
Symptoms of the subcutaneous panniculitis-like T-cell lymphoma include: | |||
* [[Fever]] | |||
* [[Weight loss]] | |||
* [[Night sweats]] | |||
* Painless swelling in the neck, axilla, groin, thorax, and abdomen | |||
=== Physical Examination === | |||
====Vitals==== | |||
* [[Fever]] is often present | |||
====Skin==== | |||
* Subcutaneous nodules | |||
====HEENT==== | |||
* [[Lymphadenopathy|Cervical lymphadenopathy]] | |||
====Thorax==== | |||
* Thoracic masses suggestive of [[Lymphadenopathy|central lymphadenopathy]] | |||
====Abdomen==== | |||
* [[Abdominal mass]]es suggestive of [[Lymphadenopathy|central lymphadenopathy]] | |||
* [[Hepatosplenomegaly]] | |||
====Extremities==== | |||
* [[Lymphadenopathy|Peripheral lymphadenopathy]] | |||
===Laboratory Findings === | |||
Laboratory tests for subcutaneous panniculitis-like T-cell lymphoma include: | |||
* [[Complete blood count]] (CBC): cytopenia | |||
* Blood chemistry studies: Increased [[liver function tests]] | |||
* Cytogenetic analysis | |||
* [[Flow cytometry]] | |||
====Biopsy==== | |||
Lymph node or bone marrow biopsy is diagnostic of subcutaneous panniculitis-like T-cell lymphoma. | |||
====CT ==== | |||
[[CT]] scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma. | |||
==== MRI ==== | |||
[[MRI]] scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma. | |||
==== Other Imaging Findings ==== | |||
[[PET]] scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma. | |||
==Treatment== | |||
== | ===Medical Therapy=== | ||
== Treatment == | {| style="border: 0px; font-size: 90%; margin: 3px;" align=center | ||
|+ '''Treatment of subcutaneous panniculitis-like T-cell lymphoma<ref name= canadiancancer>Subcutaneous panniculitis-like T-cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/subcutaneous-panniculitis-like-t-cell-lymphoma/?region=nb. Accessed on March 8, 2016 </ref> | |||
! style="background: #4479BA; color:#FFF;" | Therapy | |||
! style="background: #4479BA; color:#FFF;" | Description | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | [[Chemotherapy]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Combination therapy : | |||
:* CHOP – [[Cyclophosphamide]] {{and}} [[Doxorubicin]] {{and}} [[Vincristine]] {{and}} [[Prednisone]] | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | [[Radiation therapy]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* [[External beam radiation therapy]] may be used to treat the lymph nodes. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | [[Stem cell transplant]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* May be used in some people with subcutaneous panniculitis-like T-cell lymphoma when their lymphoma recurs after treatment. | |||
|} | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Disease]] | |||
[[Category:Oncology]] |
Revision as of 15:32, 8 March 2016
For patient information, click Insert page name here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Synonyms and keywords:
Overview
Pathophysiology
Associated Conditions
Microscopic Pathology
Causes
There are no established causes for subcutaneous panniculitis-like T-cell lymphoma.
Differentiating type page name here from other Diseases
Subcutaneous panniculitis-like T-cell lymphoma must be differentiated from other diseases such as:
Epidemiology and Demographics
Age
The incidence of subcutaneous panniculitis-like T-cell lymphoma increases with age; the median age at diagnosis is 35 years.
Gender
Females are more commonly affected with subcutaneous panniculitis-like T-cell lymphoma than males.
Risk Factors
There are no established risk factors for subcutaneous panniculitis-like T-cell lymphoma.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for subcutaneous panniculitis-like T-cell lymphoma.[1]
Natural History, Complications and Prognosis
Diagnosis
Staging
Staging for subcutaneous panniculitis-like T-cell lymphoma is provided in the following table:[2]
Stage | Involvement | Extranodal (E) status |
---|---|---|
Limited | ||
Stage I | One node or a group of adjacent nodes | Single extranodal lesions without nodal involvement |
Stage II | Two or more nodal groups on the same side of the diaphragm | Stage I or II by nodal extent with limited contiguous extranodal involvement |
Stage II bulky | II as above with "bulky" disease | Not applicable |
Advanced | ||
Stage III | Nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement | Not applicable |
Stage IV | Additional noncontiguous extralymphatic involvement | Not applicable |
Symptoms
Symptoms of the subcutaneous panniculitis-like T-cell lymphoma include:
- Fever
- Weight loss
- Night sweats
- Painless swelling in the neck, axilla, groin, thorax, and abdomen
Physical Examination
Vitals
- Fever is often present
Skin
- Subcutaneous nodules
HEENT
Thorax
- Thoracic masses suggestive of central lymphadenopathy
Abdomen
- Abdominal masses suggestive of central lymphadenopathy
- Hepatosplenomegaly
Extremities
Laboratory Findings
Laboratory tests for subcutaneous panniculitis-like T-cell lymphoma include:
- Complete blood count (CBC): cytopenia
- Blood chemistry studies: Increased liver function tests
- Cytogenetic analysis
- Flow cytometry
Biopsy
Lymph node or bone marrow biopsy is diagnostic of subcutaneous panniculitis-like T-cell lymphoma.
CT
CT scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.
MRI
MRI scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.
Other Imaging Findings
PET scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.
Treatment
Medical Therapy
Therapy | Description |
---|---|
Chemotherapy |
|
Radiation therapy |
|
Stem cell transplant |
|
References
- ↑ Recommendations. U.S Preventive Services Task Force. Accessed on March 8, 2016
- ↑ Cheson, Bruce D.; Fisher, Richard I.; Barrington, Sally F.; Cavalli, Franco; Schwartz, Lawrence H.; Zucca, Emanuele; Lister, T. Andrew; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute (2014-09-20). "Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification". Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 32 (27): 3059–3068. doi:10.1200/JCO.2013.54.8800. ISSN 1527-7755. PMID 25113753.
- ↑ Subcutaneous panniculitis-like T-cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/subcutaneous-panniculitis-like-t-cell-lymphoma/?region=nb. Accessed on March 8, 2016